AURX
Live / Registered — Registered — Section 8 accepted (as of 19 Dec 2024)
What this means for you
Registered since 27 Feb 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87235356
- Registration number
- 5413895
- Mark type
- Stylized text
- Filed
- 14 Nov 2016
- Published for opposition
- 15 Aug 2017
- Registered
- 27 Feb 2018
- Attorney of record
- Kim R. Pearson
Goods and services
- Class 005 — Pharmaceuticals: Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing short-chain fatty acids in single molecule form with a release agent that enhances solubility and absorption; nutritional ingredients, namely, a blend of nutrients, namely, short-chain fatty acids in single molecule form with a release agent that ensures solubility and absorption, that are an integral component of medicals foods, for short-chain fatty acid deficiencies in individuals with Autism Spectrum Disorder; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations to mitigate short-chain fatty acid microbiome deficiencies in individuals with Autism Spectrum Disorder; dietary supplements for restoring health in individuals with diseases, disorders, nutritional deficiencies, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, namely, increasing butyric acid and acetic acid in the gastrointestinal tract; functional nutrients containing butyric acid and acetic acid to mitigate short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; pharmaceutical preparations to mitigate short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; specialty nutraceuticals for the dietary management of diseases, disorders, and nutritional deficiencies, namely, short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder and deficiencies of butyrate in the gastrointestinal tract
Owner
- Tesseract Medical Research, LLC, Napa, CA, US
- Tesseract Medical Research, LLC, Napa, CA, US
- Tesseract Medical Research, LLC, Napa, CA, US
Prosecution history
- 19 Dec 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 19 Dec 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 18 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Apr 2024 — TEAS SECTION 8 RECEIVED
- 27 Feb 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Feb 2018 — REGISTERED-PRINCIPAL REGISTER
- 20 Jan 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Jan 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jan 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Dec 2017 — USE AMENDMENT FILED
- 12 Jan 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Dec 2017 — TEAS STATEMENT OF USE RECEIVED
- 10 Oct 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Aug 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Aug 2017 — PUBLISHED FOR OPPOSITION